Detalhe da pesquisa
1.
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
J Immunol
; 191(12): 6261-72, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244023
2.
Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity.
Gastric Cancer
; 16(4): 571-80, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23187882
3.
Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines.
Int J Cancer
; 129(10): 2408-16, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21207425
4.
[The effect of immune-based therapy with cytotoxic T lymphocyte and molecular targeting therapy for HER2 in esophageal squamous cell carcinoma].
Gan To Kagaku Ryoho
; 38(12): 1918-20, 2011 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-22202238
5.
Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model.
PLoS One
; 9(3): e92572, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24686897
6.
Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression.
Oncoimmunology
; 1(7): 1104-1110, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23170258
7.
Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.
Nutrition
; 27(2): 146-52, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21215924
8.
Lapatinib enhances herceptin-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression.
Anticancer Res
; 31(9): 2999-3005, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868551